Background-This study quantifies the association between maternal medical
Introduction
Congenital heart defects (CHD), defined as gross structural abnormalities of the heart or intrathoracic vessels, affect 5 to 15 per 1,000 live births. [1] [2] [3] [4] CHDs constitute the most common congenital anomaly subgroup among newborns and have emerged as one of the most important causes of infant mortality. [5] [6] [7] [8] Further, CHDs have a significant impact on child and adult morbidity and disability. [7] [8] [9] [10] [11] The last two decades have seen major breakthroughs in the understanding of nonmodifiable risk factors for CHD, including the identification of specific genetic abnormalities for some CHD phenotypes. However, at most 15% of all CHD cases can be traced to a genetic cause (e.g., 8-10% have aneuploidy and 3-5% have single-gene defects). An even smaller portion can be attributable to known environmental factors such as maternal rubella infection, although a few studies suggest that the fraction of cases attributable to identifiable factors may be as high as 30% for some types of heart defects. [12] [13] [14] Nevertheless, CHD prevention has been hampered by a limited understanding of modifiable risk factors. [15] [16] [17] [18] [19] [20] One important area for focus in obstetrics is prenatal diagnosis of severe congenital heart defects. Such early diagnosis permits optimal care during pregnancy, delivery and in the newborn period (including surgical correction of the defect) and pregnancy termination for lethal and very severe heart defects. It is therefore important to identify pregnant women at higher risk for congenital heart defects in order to facilitate targeted screening. It also allows for targeted pre-conception counselling to improve reproductive outcomes and promote primary prevention.
This study was carried out to better quantify the associations between chronic conditions in pregnant women (i.e., maternal illnesses such as diabetes mellitus, hypertension, thyroid disorders, congenital heart defects, and systemic connective disorders) and CHD in offspring.
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Materials and Methods
Our population-based cohort study included all live births in Canada (excluding Quebec) for the fiscal years 2002-03 to 2010-11. Information on study subjects was obtained from the Discharge Abstract Database (DAD) of the Canadian Institute for Health Information (CIHI), which contains the abstracted and collated information from the medical records of all hospitalizations in Canada (excluding Quebec since comparable data from this province were not available in the DAD). The hospitalization data were extracted by trained medical archivists in each hospital and coded according to a specified protocol. 21 Records for the mother and the infant were deterministically linked using CIHI's common mother-infant identifiers. Included in this study were all mother-infant pairs (excluding births <22 weeks gestation or <500 grams birth weight)
who had a hospital delivery in Canada. Stillbirths were not included because a substantial fraction of stillbirths in Canada include cases that follow prenatal diagnosis and pregnancy termination, 22 and because stillbirth records could not be linked to the mothers' records.
Chronic medical conditions affecting the mother and congenital heart defects in offspring were identified based on information in the 25 diagnostic fields of the medical record, coded according to the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Canada (ICD-10 CA). The diagnosis of congenital heart defects was based on hospitalization records at childbirth and at rehospitalisation, with the latter identified through a previously validated deterministic algorithm for linking live births and readmissions that occurred within one year after birth. 23 Information in the DAD database has been previously validated, and extensively used in perinatal health surveillance and research. 3, 21, [23] [24] [25] Congenital heart defects (ICD-10 codes Q200-Q269, Q893) were classified into phenotypes based on the classification used by Botto et al 12 and Øyen et al. 2 This classification were all mother-infant pairs (excluding births <22 weeks gestation or <500 gram ms s b b bir irth th th w w wei ei eigh g ght) t)
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We also estimated the proportion of CHD cases that would be eliminated if a particular risk factor (assumed to be causally associated with CHD) was removed from the population using the adjusted effect measure in the formula Pe(RR-1)/Pe(RR-1)+1 where Pe=proportion of the population exposed to the risk factor and RR=relative risk (odds ratio given rare disease) associated with the risk factor. 28 Separate logistic models were also created to assess the relationship between chronic medical conditions and specific severe subtypes of CHD (i.e., heterotaxia, conotruncal defects, AVDS, APVR, LVOTO, RVOTO, and multiple cardiac defects consisting of conotruncal defect + AVSD, septal defect +LVOTO and septal defect + RVOTO) and also VSD and ASD. All statistical analyses were carried out using SAS version 9.2 (SAS Institute, Cary, NC, USA).
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Results
Of 2,278,838 infants born in hospitals in
The most prevalent CHD was isolated PDA with a prevalence of 38.1 per 10,000 live births, while the prevalence of isolated PDA at term was 23.7 per 10,000 live births. Isolated septal defects (e.g, ASD alone or VSD alone) were the second most prevalent cardiac defects and accounted for 27.5% of all CHDs (prevalence rate 32.0 per 10,000 live births). Other CHDs included conotruncal defects (10.4 per 10,000 live births), the combined left and right heart obstructive defects (3.4 per 10,000 live births) and atrioventricular septal defect (2.8 per 10,000 live births). Other specified CHDs accounted for 15.4% of all CHD cases (prevalence 17.9 per 10,000 live births), while unspecified cases represented approximately 5% of all CHDs ( Table   1) .
CHD prevalence was higher among infants of younger mothers, older mothers, women with a parity 2, women living in rural areas and male infants ( Table 2) . Multiple births had a substantially elevated prevalence of CHD (43.3 per 1,000 live births). The prevalence rates of CHD prevalence was 101.8 per 10,000 live births. The prevalence of severe CHD HD D w w was s 2 2 22. 2. 2 3 3 3 pe pe p r 10,000 live births ( Table 1) . 2.6% of the CHD cases could be attributed to multi-fetal pregnancy and maternal age 35 years, respectively, at the population level. As a whole, 14% of CHD cases could be prevented if all the risk factors were eliminated from the population ( Table 3) . Tables 4 and 5 show associations between chronic medical conditions in the mother and specific subtypes of CHD in the offspring. Diabetes mellitus and congenital heart disease in the mother were strong risk factors for heterotaxia, conotruncal defects, atrioventicular septal defects (AVSD), left and right ventricular outflow obstruction, septal defects and multiple defects.
Maternal connective tissue disorders were strongly associated with heterotaxia (aOR 6.8, 95% CI 1.7-27.7), while alcohol or substance use, pre-existing hypertension and multi-fetal pregnancy were significantly associated with right ventricular outflow tract obstruction, VSD and ASD. and CHD were both maternal illness and CHD phenotype-specific. Several maternal conditions such as multi-fetal pregnancy, diabetes mellitus, congenital heart defects and systemic connective tissue diseases were strongly associated with CHD.
Our prevalence estimates for overall CHD and most severe CHD subtypes were similar to those reported previously from other countries. A large number of isolated defects (i.e., isolated VSD, ASD and PDA) accounted for 60% of CHDs and this estimate is higher than those in previous reports. 19, 27, [30] [31] [32] [33] Increasing availability of echocardiography and a resultant increase in the diagnosis of minor defects in asymptomatic infants is one potential explanation 26, [31] [32] [33] [34] In addition, large variations were hose reported previously from other countries. observed between regions which may reflect true differences or possibly an artifact of differences in documentation and case ascertainment.
As in previous studies, pre-existing maternal diabetes (type 1 and 2) was observed to be a significant risk factor for CHD overall and for almost every CHD subtype. Numerous studies have shown that diabetes causes cardiovascular malformations before the seventh week of gestation, because of a link between glycemic control during organogenesis and fetal malformations. 18, [35] [36] [37] We therefore focused on assessing the risk of pre-existing diabetes in our data rather than assessing the effect of gestational diabetes. On the other hand, the elevated risk of CHD observed with some maternal chronic conditions (e.g., epilepsy and mood disorders) may be a consequence of medication used to treat those conditions, rather than the medical condition per se. Our goal, however, was to identify women at high risk for CHD irrespective of whether the chronic condition or its treatment was the true cause of CHD.
Our findings of associations between maternal chronic illnesses such as congenital heart disease and systemic connective tissue disorders and CHD were also in line with previous studies. 8, 14, 15, 29, 38 In addition, we observed that pre-existing hypertension among mothers posed an elevated risk of certain subtypes of CHD. We also observed an association between maternal cigarette smoking and congenital heart defects as in previous studies, 39, 40 and the association was specific to particular subtypes of CHD. The effects of the various maternal chronic conditions did not change appreciably when the study was restricted to singletons live births (data not shown).
The strengths of our study include its size, population-based nature, standardized data extraction and ICD-10 coding. The large study size allowed estimation of associations between relatively uncommon maternal illnesses and rare subtypes of severe CHD. Such large may be a consequence of medication used to treat those conditions, rather than th th he me me m di di dica ca cal l l condition per se. Our goal, however, was to identify women at high risk for CHD irrespective of
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It is widely acknowledged that the systems for classifying CHD are challenging, because of the wide range of known defects, differing etiology, and developmental mechanisms. Infants with multiple cardiac defects may be counted multiple times in congenital anomalies surveillance. The classification algorithm used in our study, however, assigned each infant (including those with multiple cardiac defects) to a specific cardiac phenotype among a group of exhaustive and mutually exclusive categories. This classification scheme of cardiac defects was developed with an anatomic and developmental rationale and permitted the conversion of ICD 10 diagnosis codes into a flexible coding scheme for studying CHD. Se Se Seve ve v r ra al li li im mi mita t tions inherent in our study y me me mer rit discussion. Firs rst, t t, m m maternal illnesses and pre---ex e isting con ondi d d t t tion on ns s r re reco co cord rd rde ed ed a a at t t ch ch c i i ild d dbirt th h h hosp p pi it tali iz iza at atio io on we were re l lik ik kel el e y y un un nde de der-r-re re epo po port rte ed e In summary, our study shows a declining prevalence of CHD in infants from 2002 to 2010, and a relatively low overall rate of severe CHD in Canada. Several maternal conditions/illnesses were highly associated with CHD and different maternal conditions were associated with specific CHD subtypes. Understanding these relationships and probable etiology may allow for an opportunity to promote preconception health and primary prevention.
Moreover, information on the proportion of CHD cases prevented prenatally based on the population attributable fractions estimated in our study may be helpful in identifying pregnant women at higher risk for CHD to facilitate targeted screening and selective termination for lethal and very severe heart defects. Table 5 . Associations between maternal factors (including age and chronic medical conditions) and specific congenital heart defects in offspring including right ventricular outflow tract obstruction (RVOTO), ventricular (VSD), and atrial septal defects (ASD) and multiple heart defects, Canada (excluding Quebec), 2002-2010.
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